Abstract
Distinct cellular processes mediate blood-vessel formation during embryogenesis (Beck and D’Amore 1997; Carmeliet and Collen 1998a; Folkman and D’Amore 1996; Noden 1989; Risau 1997; Wilting and Christ 1996) (Fig. 1). Initially, mesodermal cells differentiate in situ into early haemangioblasts and form cellular aggregates (blood islands), in which the inner-cell population develops into haematopoietic precursors and the outer-cell population gives rise to the primitive endothelial cells. In vitro findings suggest that basic fibroblast growth factor (bFGF or FGF2) may participate in angioblast differentiation via induction of a cellular receptor for vascular endothelial growth factor (VEGF-A) (Flamme and Risau 1992).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albini A, Soldi R, Giunciuglio D, Giraudo E, Benelli R, Primo L, Noonan D, Salio M, Camussi G, Rockl W, Bussolino F (1996) The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-l/KDR receptor on vascular endothelial cells. Nat Med 2:1371–1375.
Alon T, Hemo I, Itin A, Pe’er J, Stone J, Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024–1028.
Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM (1995) Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91:2793–2801.
Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF (1994) Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89:2183–2189.
Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336–3343.
Basic M, Edwards NA, Merrill MJ (1995) Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. Growth Factors 12:11–15.
Beck L, D’Amore P (1997) Vascular development: cellular and molecular recognition. FASEB J 1 1:365–373.
Benjamin LA, Keshet E (1997) Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94:8761–8766.
Birkenhager R, Schneppe B, Rockl W, Wilting J, Weich HA, McCarthy JE (1996) Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor. Biochem J 316:703–707.
Breier G, Clauss M, Risau W (1995) Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dyn 204:228–239.
Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157–1164.
Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler Stevenson WG, Quigley JP, Cheresh DA (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85:683–693.
Broxmeyer HE, Cooper S, Li ZH, Song HY, Kwon BS, Warren RS, Donner DB (1995) Myeloid progenitor cells regulatory effects of vascular endothelial growth factor. Int J Hematol 62:203–215.
Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG, Tsang MLS (1996a) Heterodimers of placenta growth factor/vascular endothelial growth factor: enodthelial activity, tumor cell expression, and high affinity binding to Flk-l/KDR. J Biol Chem 271:3154–3162.
Cao Y, Linden P, Shima D, Browne F, Folkman J (1996b) In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J Clin Invest 98:2507–2511.
Cao Y, Ji WR, Rosin A, Cao Y (1997) Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun 235:493–498.
Carmeliet P, Collen D (1996) Gene manipulation and transfer of the plasminogen system and coagulation system in mice. Semin Thromb Hemost 22:525–542.
Carmeliet P, Collen D (1997) Genetic analysis of blood vessel formation. Role of endothelial versus smooth muscle cells. Trends Cardiovasc Med 7:271–281.
Carmeliet P, Collen D (1997) Insights into vascular biology via targeted gene inactivation and adenovirus-mediated gene transfer of the plasminogen system. In: Feuerstein GZ (ed) Coronary restenosis. From genetics to therapeutics. Dekker, New York, pp 225–240.
Carmeliet P, Collen D (1998a) Vascular development and disorders: molecular analysis and pathogenetic insights. Kidney Int (in press).
Carmeleit P, Dor Y, Herbert JM, Fukuwara D, Brusselinans K, Swderchun M, Nilman M, Bonof, Abramovitch R, Maxwell P, Koch CJ, Ratchiffi P, Moons L, Jain RK, Collen D, Kershet E. (1998b). Role of HiF-lα in hypoxia-mediated apoptosis, cell proliferetion and tumour anjiogenesis. Nature 394:487–490.
Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Kendraprasad H, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A (1996a) Abnormal blood vessel development and lethality in embryos lacking a single vascular endothelial growth factor allele. Nature 380:435–439.
Carmeliet P, Mackman N, Moons L, Luther T, Glessens P, Van Vlaenderen 1, Demunck H, Kasper M, Breier G, Evrard P, MĂ¼ller M, Risau W, Edgington T, Collen D (1996b) Role of tissue factor in embryonic blood vessel development. Nature 383:73–75.
Clauss M, Gerlach M, Gerlach H et al. (1990) A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535–1545.
Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271:17629–17634.
Coughlin SR (1994) Molecular mechanisms of thrombin signaling. Semin Hematol 31:270–277.
Davis Smyth T, Chen H, Park J, Presta LG, Ferrara N (1996) The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J 15:4919–4927.
Dejana E (1996) Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 98:1949–1953.
Dellian M, Witwer BP, Salehi HA, Yuan F, Jain RK (1996) Quantitation and physiological characterization of angiogenic vessels in mice. Effects of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am J Pathol 149:59–71.
Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ (1996) Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated adhesion and release? J Cell Biol 134:1563–71.
De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989–991.
Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:1845–54.
DiSalvo J, Bayne ML, Conn G, Kwok PW, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA, Thomas KA (1995) Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer. J Biol Chem 270:7717–7723.
Dor Y, Keshet E (1997) Ischemia-driven angiogenesis. Trends Cardiovasc Med 7:289–294.
Drake CJ, Cheresh DA, Little CD (1995) An antagonist of integrin avĂŸ3 prevents maturation of blood vessels during embryonic neovascularization. J Cell Sci 108:2655–2661.
Drake CJ, Little CD (1995) Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci USA 92:7657–7661.
Dumont DJ, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML (1995) Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 203:80–92.
Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA, Dvorak HF (1996) The vesiculo-vacuolar organelle (VVO)- a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. Leuk Biol 59:100–115.
Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039.
Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1 alpha regulates VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 94:4273–4278.
Enholm B, Paavonen K, Ristimäki A, Kumar V, Gunji Y, Klefstrom J, Kivinen L, Laiho M, Olofsson B, Joukov V, Eriksson U, Alitalo K (1997) Comparison of VEGF, VEGF-B, VEGF-C, Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14:2475–2483.
Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4–25.
Ferrara N, Carver Moore K, Chen H, Dowd M, Lu L, O’Shea KS, Powell Braxton L, Hillan KJ, Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439–442.
Flamme I, Risau W (1992) Induction of vasculogenesis and hematopoiesis in vitro. Development 116:435–439.
Flamme I, von Reutern M, Drexler HC, Syed Ali S, Risau W (1995) Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev Biol 171:399–414.
Flamme I, Fröhlich T, von Reutern M, Kappel A, Damert A, Risau W (1997) HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-lalpha and developmentally expressed in blood vessels. Mech Dev 63:51–63.
Folkman J, D’Amore PA (1996) Blood vessel formation: what is its molecular basis? (Comment). Cell 87:1153–1155.
Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66–70.
Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270:12607–12613.
Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA (1995) Definition of two angiogenic pathways by distinct alpha v integrins. Science 270:1500–1502.
Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2:1096–1103.
Galland F, Karamysheva A, Pebusque MJ, Borg JP, Rottapel R, Dubreuil P, Rosnet O, Birnbaum D (1993) The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 8:1233–1240.
George EL, Georges Labouesse EN, Patel King RS, Rayburn H, Hynes RO (1993) Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119:1079–1091.
Gleadle JM, Ebert BL, Firth JD, Ratcliffe PJ (1995) Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol 268:C1362–C1368.
Gnarra JR, Ward JM, Porter FD, Wagner JR, Devor DE, Grinberg A, Emmert-Buck MR, Westphal H, Klaussner RD (1997) Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 94:9102–9107.
Grosskreutz CL, Anand-Apte B, Terman B, Quinn TP, D’Amore PA (1996) Vascular endothelial growth factor (VEGF) is a chemoattractant for vascular smooth muscle cells (SMC). Invest Opthalmol Vis Sci 37:5470–5475.
Gurtner GC, Davis V, Li H, McCoy MJ, Sharpe A, Cybulsky MI (1995) Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev 9:1–14.
Hanahan D (1997) Signaling vascular morphogenesis and maintenance. Science 277:48–50.
Hariawala MD, Horowitz JJ, Esakof D, Sheriff DD, Walter DH, Keyt B, Isner JM, Symes JF (1996) VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63:77–82.
Hatva E, Bohling T, Jasskelainen J, Persico MG, Haltia M, Alitalo K (1996) Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 148:763–775.
Hauser S, Weich H (1993) A heparin-binding form of placenta growth factor (P1GF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9:259–268.
Isner JM, Peiczeck A, Schainfield R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsch K, Symes JF (1996) Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348:370–374.
Iyer NV, Kotch LE, Agani E, Leung SW, Laughner E, Weugs RH, Fessmanin M, Fearhartch D, Lawler AM, Yu AY, Femenza GL (1998) Genes Acv. 12:149–162.
Jeltsch M, Kappainen AA, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423–1425.
Jing-Shan H, Hastings GA, Cherry S, Gentz R, Ruben S, Coleman TA (1997) A novel regulatory function of proteolytically cleaved VEGF-2 for vascular endothelial and smooth muscle cells. FASEB J 11:498–504.
Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290–298.
Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M, Alitalo K (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566–3570.
Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y (1995) Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res 55:5687–5692.
Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, Ferrara N (1996) The carboxyl-terminal domain (111–165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271:7788–7795.
Khaliq A, Li XF, Shams M, Sisi P, Acevedo CA, Whittle MJ, Weich H, Ahmed A (1996) Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors 13:243–250.
Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841–844.
Klagsbrun M, D’Amore PA (1996) Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 7:259–270.
Kourembanas S, Mcquillan LP, Leung GK, Faller DV (1993) Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 92:99–104.
Kozak KR, Abbott B, Hankinson O (1997) ARNT-deficient mice and placental differentiation. Dev Biol 191:247–306.
Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, Alitalo K (1996) VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122:3829–3837.
Kuzuya M, Satake S, Esaki T, Yamada K, Hayashi T, Naito M, Asai K, Iguchi A (1995) Induction of angiogenesis by smooth muscle cell-derived factor: possible role in neovascularization in atherosclerotic plaque. J Cell Physiol 164:658–667.
Kwee L, Baldwin S, Stewart C, Buck C, Labow M (1995) Defective development of the embryonic and extraembryonic circulatory system in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 121:489–503.
Lang RA, Bishop JM (1993) Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 74:453–462.
Lang R, Lustig M, Francois F, Sellinger M, Plesken H (1994) Apoptosis during macrophage-dependent ocular tissue remodelling. Development 120:3395–403.
Lee J, Gray A, Yuan J, Luoh SM, Avraham H, Wood WI (1996) Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 93:1988–1992.
Levéen P, Pekny M, Gebre Medhin S, Swolin B, Larsson E, Betsholtz C (1994) Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8:1875–1887.
Levy AP, Levy NS, Iliopoulos O, Jiang C, Kaelin WG, Goldberg MA (1997) Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene. Kidney Int 51:575–578.
Li J, Brown LF, Grossman JD, Morgan JP, Simons M (1996) VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270:H 1803–811.
Lindahl P, Johansson BR, Levéen P, Betsholtz C (1997) Pericyte loss and microaneurysm formation in PDGF-BB deficient mice. Science 277:242–245.
Lindner V, Reidy MA (1996) Expression of VEGF receptors in arteries after endothelial injury and lack of increased endothelial regrowth in response to VEGF. Arterioscler Thromb Vase Biol 16:1399–405.
Maglione D, Guerriero V, Viglietto G, Delli Bovi P, Persico MG (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267–9271.
Maisonpierre PC, Suri C, Jones PF et al. (1997) Angiopoeitin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55–60.
Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon CM (1997) Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386:403–407.
Meeson A, Palmer M, Calfon M, Lang R (1996) A relationship between apoptosis and flow during programmed capillary regression is revealed by vital analysis. Development 122:3929–3938.
Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK (1996) During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium (see comments). Nat Med 2:992–997.
Mignatti P, Rifkin DB (1996) Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49:1 17–137.
Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576–579.
Li J, Brown LF, Grossman JD, Morgan JP, Simons M (1996) VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270:H 1803–811.
Nehls V, Drenckhahn D (1993) The versatility of microvascular pericytes: from mesenchyme to smooth muscle? Histochemistry 99:1–12.
Neufeld G, Cohen T, Gitay Goren H, Poltorak Z, Tessler S, Sharon R, Gengrinovitch S, Levi BZ (1996) Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev 15:153–158.
Noden DM (1989) Embryonic origins and assembly of blood vessels. Ann Rev Respir Dis 140:1097–1103.
Nomura M, Yamagishi S, Harada S, Hayashi Y, Tamashima T, Ymashita J, Yamamoto H (1995) Possible participation of autocrine and paracrine vascular endothelial gorwth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem 270:28316–28324.
Okamota N, Tobe T, Hackett SF et al. (1997) Transgenic mice with increased expression of vascular endothelial growth factor in the retina. Am J Pathol 151:281–291.
Oloffson B, Pajusola K, Kaipainen A, von Eulen G, Joukow V, Saksela O, Orpona A, Pettersoson RF, Alitalo K, Eriksson U (1996) Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93:2576–2581.
Orlandini M, Marconcini L, Ferruzzi R, Oliviero S (1996) Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family (corrected; erratum to be published). Proc Natl Acad Sci USA 93:11675–11680.
Park JE, Chen HH, Winer J, Houck KA, Ferrara N (1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-l/KDR. J Biol Chem 269:25646–25654.
Patan S(1998) TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth (submitted)
Patan S, Alvarez MJ, Schittny JC, Burri PH (1992) Intussusceptive microvascular growth: a common alternative to endothelial sprouting. Arch Histol Cytol 55:65–75.
Patan S, Haenni B, Burri PH (1996) Implementation of intussusceptive microvascular growth in the chicken chorioallantoic membrane (CAM): 1. pillar formation by folding of the capillary wall. Microvasc Res 51:80–98.
Patan S, Haenni B, Burri PH (1997) Implementation of intussusceptive microvascular growth in the chicken chorio-allantoic membrane (CAM) 2. Pillar formation by capillary fusion. Microvasc Res 53:33–52.
Pearlman JD, Hibberd MG, Chuang ML, et al. (1995) Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med 1:1085–1089.
Pepper MS, Meda P (1992) Basic fibroblast growth factor increases junctional communication and connexin 43 expression in microvascular endothelial cells. J Cell Physiol 153:196–205.
Pertovaara L, Kaipanen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K (1994) Vascular endothelial growth factor is induced in response to transforming growth factor-ĂŸ in fibroblastic and epithelial cells. J Biol Chem 269:6271–6274.
Plate KH, Risau W (1995) Angiogenesis in malignant gliomas. Glia 15:339–347.
Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J (1995) The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14:5884–5891.
Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90:7533–7537.
Reinartz J, Schafer B, Batria R, Klein CE, Kramer MD (1995) Plasmin abrogates avĂŸ5-mediated adhesion of a human keratinocyte line (HaCat). Exp Cell Res 214:486–498.
Risau W (1995) Differentiation of endothelium. FASEB J 9:926–933.
Risau W (1997) Mechanisms of angiogenesis. Nature 386:671–674.
Robert B, St John PL, Hyink DP, Abrahams DR (1996) Evidence that embryonic kidney cells expressing flk-1 are intrinsic, vasculogenic angioblasts. Am J Physiol 271:F744–F753.
Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108:2369–2379.
Ryan HE, Lo J, Johnson RS. (1998) HiF-lα is required for solid tumour formetin and emlyonic va-senlarizetion. Erbo J. 17:3005–3015.
Sato TN, Tozawa Y, Deutsch U, Wolburg Buchholz K, Fujiwara Y, Gendron Maguire M, Gridley T, Wolburg H, Risau W, Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70–74.
Sato Y, Asada Y, Marutsuka K, Hatakeyama K, Sumiyoshi A (1996) Tissue factor induces migration of cultured aortic smooth muscle cells. Thromb Haemost 75:389–392.
Sawano A, Takahashi T, Yamaguchi S, Aonumura M, Shibuya M (1996) Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7:213–221.
Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M (1995) A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10:135–147.
Semenza GL (1996) Transcriptional regulation by hypoxia-inducible factor-1. Trends Carciovasc Med 6:151–157.
Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Perruzzi CA, Detmar M (1996) Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the avβ3 integrin, osteopontin, and thrombin. Am J Pathol 149:293–305.
Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62–66.
Shalaby F, Ho J, Stanford WL et al. (1997) A requirement for Flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89:981–990.
Soker S, Fidder H, Neufeld G, Klagsbrun M (1996) Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J Biol Chem 271:5761–5767.
Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD (1995) Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 92:11–14.
Stefansson S, Lawrence DA (1996) The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta3 binding to vitronectin. Nature 383:441–443.
Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C (1994) Macrophages and angiogenesis. J Leukoc Biol 55:410–422.
Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171–1180.
Takagi H, King GL, Aiello LP (1996) Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes 45:1016–1023.
Terman BI, Dougher Vermazen M (1996) Biological properties of VEGF/VPF receptors. Cancer Metastasis Rev 15:159–163.
Tian H, McKnight SL, Russell DW (1997) Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11:72–82.
Tuder RM, Flook BE, Voelkel NF (1995) Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 95:1798–1807.
van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM (1997) Vascular endothelial growth factor/Vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95:1030–1037.
Varner JA, Brooks PC, Cheresh DA (1995) Review: the integrin αvĂŸ3: angiogenesis and apoptosis. Cell Adhesion Commun 3:367–374.
Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, Fedele M, Ippolito P, Chiappetta G, Botti G (1995) Upregulation of vascular endothelial growth factor (VEGF) and down-regulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 11:1569–1579.
Vittet D, Buchou T, Schweitzer A, Dejana E, Huber P (1997) Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci USA 94:6273–6278.
Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K, Halmesmaki E (1997) Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 56:489–494.
Waltenberger J (1997) Modulation of growth factor action. Implications for treatment of cardiovascular diseases. Circulation 96:4083–4094.
Waltenberger J, Claesson Welsh L, Siegbahn A, Shibuya M, Heldin CH (1994) Different signal transduction properties of KDR and Fltl, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988–26995.
Ware JA, Simons M (1997) Angiogenesis in ischemic heart disease. Nat Med 3:158–163.
Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA (1996) Regulation of integrin function by the urokinase receptor. Science 273:1551–1555.
Weihrauch D, Arras M, Zimmermann R, Schaper J (1995) Importance of monocytes/macrophages and fibroblasts for healing of micronecroses in porcine myocardium. Mol Cell Biochem 147:13–19.
Wenger RH, Gassmann M (1997) Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 378:609–616.
Wilting J, Christ B (1996) Embryonic angiogenesis: a review. Naturwissenschaften 83:153–164.
Wilting J, Birkenhager R, Eichmann A, Kurz H, Martiny Baron G, Marme D, McCarthy JE, Christ B, Weich HA (1996) VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane. Dev Biol 176:76–85.
Wood SM, Gleadle JM, Pugh CQ, Hankinson O, Ratcliffe P (1996) The role of the aryl hydrocarbon receptor nuclear transporter (ARNT) in hypoxic induction of gene expression. J Biol Chem 271:15117–15123.
Yamada Y, Nezu J, Shimane M, Hirate Y (1997) Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 42:483–488.
Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J (1993) flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118:489–98.
Yang JT, Rayburn H, Hynes RO (1993) Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 119:1093–105.
Yang JT, Rayburn H, Hynes RO (1995) Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. Development 121:549–560.
Yang R, Thomas GR, Bunting S, Ko A, Ferrara N, Keyt B, Ross J, Jin H (1996) Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol 27:838–844.
Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 93:14765–14770.
Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP (1994) Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 94:1320–1327.
Zhang Y, Deng Y, Liliensiek B, Bierhaus A, Greten J, He W, Chen B, Hach-Wunderle V, Waldherr R, Ziegler R, Männet D, Stern DM, Nawroth PP (1996) Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse Meth-A sarcomas. J Clin Invest 97:2213–2224.
Zheng X, Saunders TL, Camper SA, Samuelson LC, Ginsburg D (1995) Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci USA 92:12426–12430.
Ziche M, Maglione D, Ribatti D, Morbidelli L, Lago CT, Battisti M, Poaletti I, Barra A, Tucci M, Parise G, Vincenti V, Granger HJ, Viglietto G, Persico MG (1997) Placenta growth factor-1 is chemotactic, mitogenic and angiogenic. Lab Invest 76:517–531.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Carmeliet, P., Collen, D. (1999). Role of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptors in Vascular Development. In: Claesson-Welsh, L. (eds) Vascular Growth Factors and Angiogenesis. Current Topics in Microbiology and Immunology, vol 237. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59953-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-59953-8_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64195-4
Online ISBN: 978-3-642-59953-8
eBook Packages: Springer Book Archive